Sinofn Health
Sinofn Health
In the rapidly expanding sector of functional foods, Tremella Polysaccharide has emerged as a cornerstone bioactive compound. Often referred to as the "Hyaluronic Acid of the East," its unique molecular structure and superior water-binding capacity have made it an indispensable ingredient for manufacturers specializing in beauty-from-within and cognitive health solutions. As premier OEM Tremella Polysaccharide manufacturers, we recognize that the future of this industry lies not just in volume production, but in the sophisticated application of biotechnological extraction methods.
Our manufacturing philosophy is rooted in E-E-A-T (Experience, Expertise, Authoritativeness, Trustworthiness). We operate at the intersection of traditional wisdom and modern biochemical engineering. Tremella fuciformis, when processed through high-precision enzymatic hydrolysis, yields a low-molecular-weight polysaccharide that exhibits enhanced absorption. At SINOFN, our R&D center focuses on standardizing the degree of polymerization to ensure that our OEM partners receive raw materials that offer consistent functionality across diverse end-product formulations, from solid drinks to encapsulations.
The global demand for plant-based, clean-label ingredients is driving a strategic shift in procurement. Brands are moving away from mere commodity purchasing toward deep-partnering with vertically integrated manufacturers. By partnering with a factory that manages the lifecycle—from cultivation supervision to final product packaging—brands minimize the "quality drift" often associated with fragmented supply chains. SINOFN provides this transparency, utilizing blockchain tracking and rigorous stability testing to ensure every batch meets international standards (ISO 22000, HACCP, FSSC 22000).
Founded in 2012, SINOFN is more than a manufacturing facility; we are a dedicated partner in metabolic health and functional nutrition. Our journey, originating from the mission to provide accessible nutrition for children with Phenylketonuria (PKU), has ingrained a culture of precision that we apply to every Tremella Polysaccharide project.
Led by Dr. Zhang Ying (Chinese Academy of Sciences) and Dr. Tan Shengjie (Peking University Medical Doctor), our scientific team bridges the gap between clinical research and industrial-scale production. We do not just manufacture; we innovate.
With 71+ registered trademarks and 36 patents, our intellectual property portfolio guarantees that your product is not only compliant with global regulations but also protected. We maintain a full-plant integration model that covers raw material storage, production, and BRCGS-certified warehousing.
Q: What makes your Tremella Polysaccharide OEM process different?
A: We utilize proprietary extraction technologies that preserve the bioactivity of the polysaccharides, ensuring high efficacy for collagen-boosting and immunity-supporting applications.
Q: Can you support rapid prototyping for new product development?
A: Absolutely. Our pilot-scale prototyping facilities allow us to test tablet, capsule, and liquid formulations before moving to full-scale production, ensuring time-to-market efficiency for your brand.
Q: Do you support global regulatory documentation for export?
A: Yes. As an experienced international supplier, we manage the necessary certifications and documentation for global market entry, aligning with local compliance standards.
